June 25, 2008

Geisinger Health Selects Carestream’s Optical Molecular Imaging Technology

Carestream Health has announced that Geisinger Health System's Neuroscience Institute is using its latest optical molecular imaging technology as part of research of brain cancer treatment.

The objective of this research is to make surgery for brain tumors and inflammatory lesions simpler and more precise by using fluorescent nanospheres to more easily visualize tumors and lesions during treatment procedures, said Carestream Health.

Geisinger's neuroscience lab chose the company's Kodak in-vivo multispectral imaging system FX to assess which nanoparticles would be most efficacious for image-guided brain surgery in patients in the near future.